Aspira Women's Health Inc.

NASDAQ:AWH

0.86 (USD) • At close November 5, 2024
Bedrijfsnaam Aspira Women's Health Inc.
Symbool AWH
Munteenheid USD
Prijs 0.864
Beurswaarde 13,878,345
Dividendpercentage 0%
52-weken bereik 0.74 - 5.65
Industrie Diagnostics & Research
Sector Healthcare
CEO Ms. Nicole Sandford CPA
Website https://aspirawh.com

An error occurred while fetching data.

Over Aspira Women's Health Inc.

Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the

Vergelijkbare Aandelen

Modular Medical, Inc. logo

Modular Medical, Inc.

MODD

2.26 USD

IRIDEX Corporation logo

IRIDEX Corporation

IRIX

1.4 USD

PharmaCyte Biotech, Inc. logo

PharmaCyte Biotech, Inc.

PMCB

1.74 USD

Larimar Therapeutics, Inc. logo

Larimar Therapeutics, Inc.

LRMR

7.36 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)